Universal Clinical Codes & Terminology Search

Initiation and monitoring marginal (extended) cadaver donor lung(s) organ perfusion system by physician or qualified health care professional including physiological and laboratory assessment (eg pulmonary artery flow pulmonary artery pressure left atrial pressure pulmonary vascular resistance mean/peak and plateau airway pressure dynamic compliance and perfusate gas analysis) including bronchoscopy and X ray when performed; first two hours in sterile field

Oncology (prostate) analysis of circulating plasma proteins (tPSA fPSA KLK2 PSP94 and GDF15) germline polygenic risk score (60 variants) clinical information (age family history of prostate cancer prior negative prostate biopsy) algorithm reported as risk of likelihood of detecting clinically significant prostate cancer

Initiation and monitoring marginal (extended) cadaver donor lung(s) organ perfusion system by physician or qualified health care professional including physiological and laboratory assessment (eg pulmonary artery flow pulmonary artery pressure left atrial pressure pulmonary vascular resistance mean/peak and plateau airway pressure dynamic compliance and perfusate gas analysis) including bronchoscopy and X ray when performed; each additional hour (List separately in addition to code for primary p

Oncology (colorectal) cell-free DNA 8 genes for mutations 7 genes for methylation by real-time RT-PCR and 4 proteins by enzyme-linked immunosorbent assay blood reported positive or negative for colorectal cancer or advanced adenoma risk

External patient-activated physician- or other qualified health care professional-prescribed electrocardiographic rhythm derived event recorder without 24 hour attended monitoring; in-office connection

Oncology (prostate) mRNA gene-expression profiling by real-time RT-PCR of 6 genes (FOXM1 MCM3 MTUS1 TTC21B ALAS1 and PPP2CA) utilizing formalin-fixed paraffin-embedded (FFPE) tissue algorithm reported as a risk score for prostate cancer

External patient-activated physician- or other qualified health care professional-prescribed electrocardiographic rhythm derived event recording without 24 hour attended monitoring; review and interpretation by a physician or other qualified health care professional per 30 days with at least one patient-generated triggered event

Oncology (colorectal) next-generation sequencing for mutation detection in 43 genes and methylation pattern in 45 genes blood and formalin-fixed paraffin-embedded (FFPE) tissue report of variants and methylation pattern with interpretation

Cystourethroscopy with mechanical dilation and urethral therapeutic drug delivery for urethral stricture or stenosis including fluoroscopy when performed

Oncology (colorectal and lung) DNA from formalin-fixed paraffin-embedded (FFPE) tissue next-generation sequencing of 8 genes (NRAS EGFR CTNNB1 PIK3CA APC BRAF KRAS and TP53) mutation detection

Initial prenatal care visit (report at first prenatal encounter with health care professional providing obstetrical care. Report also date of visit and in a separate field the date of the last menstrual period [LMP]) (Prenatal)

Infectious agent detection by nucleic acid (DNA or RNA) human papillomavirus (HPV) for five or more separately reported high-risk HPV types (eg 16 18 31 33 35 39 45 51 52 56 58 59 68) (ie genotyping)

Autoinflammatory disease (VEXAS syndrome) DNA UBA1 gene mutations targeted variant analysis (M41T M41V M41L c.118-2A>C c.118-1G>C c.118-9_118-2del S56F S621C)

Prenatal flow sheet documented in medical record by first prenatal visit (documentation includes at minimum blood pressure weight urine protein uterine size fetal heart tones and estimated date of delivery). Report also: date of visit and in a separate field the date of the last menstrual period [LMP] (Note: If reporting 0501F Prenatal flow sheet it is not necessary to report 0500F Initial prenatal care visit) (Prenatal)

Noninvasive estimated coronary fractional flow reserve (FFR) derived from coronary computed tomography angiography data using computation fluid dynamics physiologic simulation software analysis of functional data to assess the severity of coronary artery disease; data preparation and transmission analysis of fluid dynamics and simulated maximal coronary hyperemia generation of estimated FFR model with anatomical data review in comparison with estimated FFR model to reconcile discordant data inte

Oncology (colorectal) blood quantitative measurement of cell-free DNA (cfDNA)

Subsequent prenatal care visit (Prenatal) [Excludes: patients who are seen for a condition unrelated to pregnancy or prenatal care (eg an upper respiratory infection; patients seen for consultation only not for continuing care)]

Noninvasive estimated coronary fractional flow reserve (FFR) derived from coronary computed tomography angiography data using computation fluid dynamics physiologic simulation software analysis of functional data to assess the severity of coronary artery disease; data preparation and transmission

Human papillomavirus (HPV) E6/E7 markers for high-risk types (16 18 31 33 35 39 45 51 52 56 58 59 66 and 68) cervical cells branched-chain capture hybridization reported as negative or positive for high risk for HPV

Postpartum care visit (Prenatal)